Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Drops Damages Provisions From Patent Reform Legislation

This article was originally published in The Pink Sheet Daily

Executive Summary

House Judiciary Committee Chairman says his panel is close to completing a draft patent reform bill.

You may also be interested in...



Patent Bill Drama Moves To House As Senate Hands Brand Pharma Victory

With the Senate poised to approve its version of the patent reform bill, House Judiciary Committee Chairman Lamar Smith, R-Texas, will soon be in the driver's seat of a piece of legislation that could significantly alter the relationships pharmaceutical companies have with both their licensing partners and generic adversaries.

Patent Bill Drama Moves To House As Senate Hands Brand Pharma Victory

With the Senate poised to approve its version of the patent reform bill, House Judiciary Committee Chairman Lamar Smith, R-Texas, will soon be in the driver's seat of a piece of legislation that could significantly alter the relationships pharmaceutical companies have with both their licensing partners and generic adversaries.

Patent Bill Clears Senate Judiciary Cmte. Unanimously, But Floor Fight Looms

During markup the committee adopted an amendment to remove language that set a new standard for willful infringement; other provisions affecting the pharmaceutical industry remain intact.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071931

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel